An Overview of Corona Charged Aerosol Detection in Pharmaceutical Analysis

By Michael Swartz, Ph. D., Mark Emanuele, Amber Awad, Adam Grenier, and Deborah Hartley

Corona charged aerosol detection (CAD®) has become a widely used technology in the pharmaceutical laboratory. From formulation to stability and even QC, many analysts are turning to this technology due to its advantages of sensitivity, ease of use, dynamic range, and applicability to a wide range of analyses in the drug development process.

A white paper from Synomics Pharma, titled “An Overview of Corona Charged Aerosol Detection in Pharmaceutical Analysis”, examines the operation and use of CAD in a regulated environment, briefly addressing method development and validation specifics, and highlights a few examples illustrating some of its advantages when used in the pharmaceutical laboratory.

To download the white paper, please fill out the form below.

*FIRST NAME:
*LAST NAME:
*TITLE:
*COMPANY:
*ADDRESS:
*CITY:
*STATE:
US & Canada only
*ZIP:
*COUNTRY:
*E-MAIL:
*PHONE:

* required fields